跳至主要内容
临床试验/JPRN-UMIN000037723
JPRN-UMIN000037723已完成未知

A biomarker study of soluble immune markers in stage II-IIIA non-small cell lung cancer (WJOG12319LTR) - A soluble immune biomarker study in resectable non-small cell lung cancer (WJOG12319LTR)

West Japan Oncology Group0 个研究点目标入组 152 人开始时间: 2019年8月26日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

招募中
不适用
A study using plasma samples obtained in the JACCRO GC-08 studyGastric Cancer
JPRN-UMIN000043051Japan Clinical Cancer Research Organization (JACCRO)501
招募中
不适用
Effects of clown intervention on the psychological stress and fatigue in children and adolescents with cancer receiving chemotherapyneoplasms. fatigue. stress, psychological.C23.888.369F01.145.126.990
RBR-2gykb2Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo
尚未招募
不适用
Immunohematogical markers in Graves disease
CTRI/2021/12/038899Jayanthy Ramesh
进行中(未招募)
不适用
Profile of soluble and cellular biomarkers and of functional imaging during antiangiogenic therapies in cancer patients - PRAEMARKERAAT08The present project is an academic clinical trial in which patient suffering from hepatocellular carcinoma, non-small cell lung cancer, renal cell cancer and colorectal cancer treated routinely with antiangiogenic agents. The study protocol intends to include ten patients per tumour entitity (n=40), treated either with Sorafenib (Nexavar), Bevacizumab (Avastin) or Sunitinib (Sutent), which are all approved antiangiogenic drugs in Austria in one of the cancer types defined above.
EUCTR2008-008852-18-ATMedizinische Universität Innsbruck Innere Medizin V
招募中
不适用
Detection of markers for immune pathophysiology and analysis of their prognostic value in patients with chronic thrombocytopenia without an increase in the number of bone marrow megakaryocytes: a prospective observation study.Pancytopenia, thrombocytopenia
JPRN-UMIN000002729Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science.50